“It first happened ten or twelve years ago, related to innovations in the production process where producers found a way to produce MDMA in the laboratory without the precursor of safrole oil.

The interest in psychedelics has reemerged as clinical studies recognise the medicinal value of substances such as MDMA, mushrooms and LSD. The combination of psychotherapy and psychedelic ...